Literature DB >> 2875317

Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60.

A Amery, W Birkenhäger, R Brixko, C Bulpitt, D Clement, M Deruyttere, A De Schaepdryver, C Dollery, R Fagard, F Forette.   

Abstract

Results of the European Working Party on High Blood Pressure in the Elderly (EWPHE) trial have been analysed in relation to age, sex, blood pressure, and previous cardiovascular disease. Cardiovascular mortality and the cardiovascular study-terminating events were significantly and independently related to treatment, age, cardiovascular complications at randomisation, and systolic but not diastolic blood pressure. The benefits of treatment observed in the trial seemed to be independent of entry blood pressure and the presence or absence of cardiovascular complications at entry. There was some evidence that treatment effect decreases with advancing age. Little or no benefit from treatment could be demonstrated in patients over the age of 80 years, the great majority of whom were women.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875317     DOI: 10.1016/s0140-6736(86)92424-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  45 in total

1.  Management of elderly patients with sustained hypertension.

Authors:  K Beard; C Bulpitt; H Mascie-Taylor; K O'Malley; P Sever; S Webb
Journal:  BMJ       Date:  1992-02-15

Review 2.  Is hypertension in the elderly over-treated?

Authors:  B Lernfelt; S Landahl
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

Review 3.  Effectiveness of care for older people: a review.

Authors:  C R Victor; I Higginson
Journal:  Qual Health Care       Date:  1994-12

Review 4.  Hypertension.

Authors:  G W Ching; D G Beevers
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

5.  Effects of Age and Functional Status on the Relationship of Systolic Blood Pressure With Mortality in Mid and Late Life: The ARIC Study.

Authors:  B Gwen Windham; Michael E Griswold; Seth Lirette; Anna Kucharska-Newton; Randi E Foraker; Wayne Rosamond; Josef Coresh; Stephen Kritchevsky; Thomas H Mosley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-25       Impact factor: 6.053

Review 6.  Clinical trials and clinical practice in the elderly. A focus on hypertension.

Authors:  M E Kitler
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

Review 7.  The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.

Authors:  C J Bulpitt; A E Fletcher; A Amery; J Coope; J G Evans; S Lightowlers; K O'Malley; A Palmer; J Potter; P Sever
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

Review 8.  Prognostic significance of blood pressure in the very old. Implications for the treatment decision.

Authors:  C J Bulpitt; A E Fletcher
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

Review 9.  Cardiovascular risk factors in perspective.

Authors:  S G Carruthers
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

10.  Scoring system to identify men at high risk of stroke: a strategy for general practice.

Authors:  W G Coppola; P H Whincup; O Papacosta; M Walker; S Ebrahim
Journal:  Br J Gen Pract       Date:  1995-04       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.